Tag: United States

eli-lilly-to-test-obesity-medications-for-alcohol-and-drug-addiction-ceo-announces-study

Eli Lilly to Test Obesity Medications for Alcohol and Drug Addiction: CEO Announces Study

Eli Lilly Breaks New Ground in Addiction Treatment ResearchEli Lilly, the pharmaceutical giant behind the popular weight loss drug Zepbound, has made a groundbreaking announcement. The company is set to embark on a study...
news-26112024-115233

Roche Lung Cancer Study: Immunotherapy Failures and Drug Target Questions

Roche, a pharmaceutical company, recently announced that an experimental cancer treatment they were working on, called tiragolumab, did not improve survival rates in a major lung cancer study. The study, known as SKYSCRAPER-01, involved...
patrizia-cavazzoni-departs-fdas-drug-center-what-it-means-for-the-agency

Patrizia Cavazzoni Departs FDA’s Drug Center: What it Means for the Agency

Patrizia Cavazzoni’s Departure and Its Implications for the FDAPatrizia Cavazzoni, the esteemed leader of the Food and Drug Administration’s Center for Drug Evaluation and Research (CDER), has announced her departure from the agency on...
navigating-the-latest-changes-in-the-ndustry-up-and-down-the-career-ladder

Navigating the Latest Changes in the Industry: Up and Down the Career Ladder

Exciting Changes in the Pharmaceutical IndustryLipigon Pharmaceuticals, a leading player in the pharmaceutical industry, has recently made a significant change at the top with the appointment of Johan Liwing as their new chief executive...
understanding-palliative-care-nsights-from-a-professional-nh-medlineplus-magazine

Understanding Palliative Care: Insights from a Professional | NIH MedlinePlus Magazine

Understanding Palliative Care: A Compassionate GuideIn the realm of healthcare, when serious or terminal illnesses strike, patients and their families are often left grappling with difficult decisions and overwhelming emotions. The vast array of...
advancements-in-sanofis-treatment-for-rare-platelet-destroying-disease

Advancements in Sanofi’s Treatment for Rare Platelet-Destroying Disease

Sanofi's Breakthrough Treatment for Rare Platelet-Destroying Disease The annual meeting of the American Society of Hematology showcased exciting developments in the treatment of a rare autoimmune disorder called immune thrombocytopenia (ITP). Sanofi, a French pharma...
bestselling-bed-sheets-loved-by-readers-top-picks-and-reviews

Bestselling Bed Sheets Loved by Readers: Top Picks and Reviews

Although many may not give much thought to the sheets they sleep on, the reality is that quality bedding can make a significant difference in your sleep experience. From luxurious bamboo options to cooling...
simplified-heart-failure-risk-estimation-model-for-cost-effective-analysis

Simplified Heart Failure Risk Estimation Model for Cost-Effective Analysis

Revolutionizing Heart Failure Risk Estimation In a groundbreaking development, the American Heart Association introduced the PREVENT calculator, a transformative tool that redefines cardiovascular risk assessment. Released just over a year ago, this innovative model represents...
first-drug-approval-johnson-johnson-targets-smoldering-myeloma-treatment

First Drug Approval: Johnson & Johnson Targets Smoldering Myeloma Treatment

Johnson & Johnson Seeks Drug Approval for Smoldering Myeloma TreatmentJohnson & Johnson is making waves in the medical community with their recent push for the first drug approval aimed at treating smoldering myeloma, a...
revolutionary-biotech-battle-mpact-on-transplants-in-mantle-cell-lymphoma

Revolutionary Biotech Battle: Impact on Transplants in Mantle Cell Lymphoma

Revolutionary Biotech Battle: Impact on Transplants in Mantle Cell LymphomaIn a groundbreaking showdown at the ASH 2024 conference, the biotech world witnessed an intense rivalry between Arcellx and Legend Biotech over their anti-BCMA CAR-T...
sanofi-faces-federal-threats-over-payment-terms-change-for-drug-discount-program

Sanofi Faces Federal Threats Over Payment Terms Change for Drug Discount Program

Sanofi Faces Federal Threats Over Payment Terms Change for Drug Discount ProgramA recent warning from a U.S. government agency has put pharmaceutical giant Sanofi in hot water over its decision to alter payment terms...
news-28112024-060221

Building Resilient Healthcare: Vanessa Kerry’s Climate Change Mission

Vanessa Kerry, a physician specializing in pulmonary and critical care, established Seed Global Health over a decade ago to address disparities in healthcare systems worldwide, particularly in countries with limited resources. In a recent...